Capital World Investors holds 0.5% of Exact Sciences

Exact Sciences Corp. received an updated ownership report from Capital World Investors, a division of Capital Research and Management Company and its affiliates.

Rhea-AI Filing Summary

Exact Sciences Corp. received an updated ownership report from Capital World Investors, a division of Capital Research and Management Company and its affiliates. Capital World Investors is deemed to beneficially own 968,232 shares of Exact Sciences common stock, representing 0.5% of the 189,916,880 shares believed to be outstanding as of the reporting date.

The filing states that Capital World Investors has sole voting power over 968,142 shares and sole dispositive power over 968,232 shares, with no shared voting or dispositive power. It also certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Exact Sciences.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake does Capital World Investors report in Exact Sciences (EXAS)?

Capital World Investors reports beneficial ownership of 968,232 shares of Exact Sciences common stock, representing 0.5% of the 189,916,880 shares believed to be outstanding. This reflects a relatively small, passive institutional stake in EXAS.

Does Capital World Investors claim control intent over Exact Sciences (EXAS)?

No. Capital World Investors certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Exact Sciences, nor in connection with any transaction intended to have that effect.

How many Exact Sciences (EXAS) shares can Capital World Investors vote and dispose of?

Capital World Investors reports sole voting power over 968,142 shares and sole dispositive power over 968,232 shares of Exact Sciences common stock. It reports no shared voting or dispositive power with any other party in this Schedule 13G/A.

Why did Capital World Investors file this Schedule 13G/A for Exact Sciences (EXAS)?

The Schedule 13G/A reports Capital World Investors’ beneficial ownership of Exact Sciences common stock as of 12/31/2025. The amendment updates its holdings and confirms they are held passively, without intent to change or influence control of the company.

What does ‘ownership of 5 percent or less of a class’ mean for EXAS in this filing?

Item 5 notes that Capital World Investors holds 5 percent or less of Exact Sciences’ common stock. Specifically, it reports a 0.5% stake, indicating a relatively small institutional position compared with the company’s total shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 05:32 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

Exact Sciences Corp.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

30063P105

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 30063P105

1

Names of Reporting Persons

Capital World Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 968,142.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 968,232.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

968,232.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.5 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Exact Sciences Corp.
(b)	Address of issuer's principal executive offices: 5505 ENDEAVOR LANE, MADISON, WI 53719
Item 2.
(a)	Name of person filing: Capital World Investors
(b)	Address or principal business office or, if none, residence: 333 SOUTH HOPE STREET, 55TH FLOOR, LOS ANGELES, CALIFORNIA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 30063P105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 968,232 ** **Capital World Investors ("CWI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CWI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital World Investors." CWI is deemed to be the beneficial owner of 968,232 shares or 0.5% of the 189,916,880 shares believed to be outstanding.
(b)	Percent of class: 0.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 968,142
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 968,232
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital World Investors

Signature:	Timothy J. Moon
Name/Title:	Vice President and Senior Counsel, Capital Research and Management Company
Date:	02/10/2026